Phase 2a Study on Allogeneic Osteoblastic Cells Implantation in Lumbar Spinal Fusion

NCT02205138 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Disc Disease

Interventions

DRUG: ALLOB® cells with ceramic scaffold

Sponsor

Bone Therapeutics S.A